ERBB2 and cancer: Some studies have reported a positive correlation between HER2 overexpression and the clinical features of the tumor, such as tumor size, lymph node metastasis, local invasion, and cancer stage; whereas other studies insisted no relationship between them [20,21,22,23,24,25,26].